Lincoln National Corp’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-14,434
| Closed | -$4.1M | – | 60 |
|
|
2024
Q1 | $4.1M | Buy |
14,434
+918
| +7% | +$269K | 0.06% | 186 |
|
|
2023
Q4 | $3.89M | Buy |
13,516
+1,685
| +14% | +$459K | 0.07% | 178 |
|
|
2023
Q3 | $3.18M | Buy |
11,831
+1,206
| +11% | +$301K | 0.06% | 180 |
|
|
2023
Q2 | $2.36M | Buy |
10,625
+658
| +7% | +$153K | 0.05% | 217 |
|
|
2023
Q1 | $2.41M | Buy |
9,967
+350
| +4% | +$85.9K | 0.05% | 200 |
|
|
2022
Q4 | $2.53M | Buy |
9,617
+1,125
| +13% | +$302K | 0.06% | 192 |
|
|
2022
Q3 | $1.91M | Buy |
8,492
+410
| +5% | +$99.4K | 0.05% | 214 |
|
|
2022
Q2 | $1.97M | Sell |
8,082
-405
| -5% | -$99.2K | 0.05% | 216 |
|
|
2022
Q1 | $2.05M | Buy |
8,487
+5
| +0.1% | +$1.15K | 0.04% | 225 |
|
|
2021
Q4 | $1.91M | Sell |
8,482
-785
| -8% | -$166K | 0.04% | 230 |
|
|
2021
Q3 | $1.97M | Sell |
9,267
-592
| -6% | -$136K | 0.04% | 206 |
|
|
2021
Q2 | $2.4M | Sell |
9,859
-581
| -6% | -$143K | 0.05% | 185 |
|
|
2021
Q1 | $2.6M | Buy |
10,440
+547
| +6% | +$131K | 0.06% | 168 |
|
|
2020
Q4 | $2.27M | Buy |
9,893
+956
| +11% | +$220K | 0.06% | 165 |
|
|
2020
Q3 | $2.27M | Buy |
8,937
+237
| +3% | +$58.7K | 0.07% | 154 |
|
|
2020
Q2 | $2.05M | Buy |
8,700
+1,019
| +13% | +$232K | 0.07% | 154 |
|
|
2020
Q1 | $1.56M | Sell |
7,681
-715
| -9% | -$156K | 0.06% | 154 |
|
|
2019
Q4 | $2.02M | Buy |
8,396
+1,310
| +18% | +$289K | 0.07% | 155 |
|
|
2019
Q3 | $1.37M | Buy |
7,086
+578
| +9% | +$111K | 0.05% | 174 |
|
|
2019
Q2 | $1.2M | Buy |
6,508
+319
| +5% | +$57.1K | 0.05% | 176 |
|
|
2019
Q1 | $1.18M | Sell |
6,189
-77
| -1% | -$14.7K | 0.05% | 179 |
|
|
2018
Q4 | $1.22M | Buy |
6,266
+176
| +3% | +$34.3K | 0.06% | 145 |
|
|
2018
Q3 | $1.26M | Buy |
6,090
+114
| +2% | +$22.5K | 0.04% | 151 |
|
|
2018
Q2 | $1.1M | Buy |
5,976
+176
| +3% | +$31.1K | 0.04% | 161 |
|
|
2018
Q1 | $988K | Buy |
5,800
+142
| +3% | +$26.1K | 0.04% | 162 |
|
|
2017
Q4 | $984K | Buy |
5,658
+2,842
| +101% | +$503K | 0.03% | 235 |
|
|
2017
Q3 | $525K | Sell |
2,816
-299
| -10% | -$53K | 0.02% | 211 |
|
|
2017
Q2 | $537K | Buy |
3,115
+670
| +27% | +$109K | 0.03% | 185 |
|
|
2017
Q1 | $401K | Sell |
2,445
-10,812
| -82% | -$1.8M | 0.02% | 218 |
|
|
2016
Q4 | $1.94M | Buy |
13,257
+413
| +3% | +$62.2K | 0.11% | 79 |
|
|
2016
Q3 | $2.14M | Buy |
12,844
+1,014
| +9% | +$171K | 0.12% | 69 |
|
|
2016
Q2 | $1.8M | Buy |
11,830
+7,657
| +183% | +$1.19M | 0.11% | 79 |
|
|
2016
Q1 | $626K | Buy |
+4,173
| New | +$620K | 0.04% | 140 |
|
Other funds holding AMGN
Lincoln National Corp's AMGN Position: Q2 2024 in Review
Lincoln National Corp sold out of Amgen (AMGN) in Q2 2024, closing a stake of 14,434 shares — an estimated $4.1M sold.
Lincoln National Corp first reported a position in AMGN in Q1 2016 and held it in 33 quarters. The position peaked at $4.1M in Q1 2024. 2,784 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.
- Lincoln National Corp reported no remaining Amgen position as of Q2 2024 after selling out during the quarter.
- Lincoln National Corp sold 14,434 Amgen shares in Q2 2024, an estimated $4.1M.
- Lincoln National Corp first reported a position in Amgen in Q1 2016 and held it in 33 quarters.
- Lincoln National Corp's Amgen position peaked at $4.1M in Q1 2024.
- 2,784 funds tracked by Wall St. Rank held Amgen as of Q2 2024.
Based on Lincoln National Corp's 13F filing for Q2 2024, filed 25 Jul 2024.